| |
No Treatment |
GnRH Antagonist + Flutamide |
GnRH Antagonist + Testosterone |
|
| Jsd |
6.3 ± 4.8 |
34.1 ± 9.8b |
4.3 ± 0.6c |
| SCARKO-jsd |
7.0 ± 3.3 |
55.3 ± 7.7b |
5.9 ± 2.1c |
|
| aThe TDI is defined as the percentage of tubules that contain 3 or more
differentiating germ cells at the B spermatogonial stage or beyond. |
| bTreated mice were significantly different from untreated mice of same
genotype. |
| cMice treated with GnRH antagonist + testosterone were significantly different
from mice of same genotype treated with GnRH antagonist + flutamide. |